DaVita Healthcare Partners | DVA

Stock Price
137.87
Daily Change
2.31 1.70%
Monthly
7.87%
Yearly
-8.13%
Q3 Forecast
136.73

Peers Price Chg Day Year Date
Acadia Healthcare 23.72 0.07 0.30% -68.98% Sep/05
Addus HomeCare 113.22 1.37 1.22% -10.41% Sep/05
Elevance Health 313.64 5.59 1.81% -42.30% Sep/05
Option Care Health 29.09 0.31 1.08% -9.38% Sep/05
Brookdale Senior Living 7.69 0.04 0.52% 14.26% Sep/05
Cardinal Health 149.56 0.22 0.15% 33.55% Sep/05
Chemed 465.63 5.93 1.29% -18.52% Sep/05
Cigna 305.31 1.28 0.42% -13.66% Sep/05
Centene 28.98 0.33 1.15% -59.11% Sep/05
Corvel 85.48 -0.49 -0.57% -15.97% Sep/05
CVS Health 73.78 0.09 0.12% 27.82% Sep/05
Quest Diagnostics 183.49 3.38 1.88% 20.12% Sep/05
DaVita Healthcare Partners 137.87 2.31 1.70% -8.13% Sep/05
Encompass Health 125.58 1.10 0.88% 37.01% Sep/05
Ensign 173.99 0.99 0.57% 16.73% Sep/05
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
HCA 420.77 9.18 2.23% 8.34% Sep/05
Humana 307.92 -4.08 -1.31% -13.89% Sep/05
Laboratory Of America 278.67 3.44 1.25% 24.30% Sep/05
McKesson 687.40 -4.05 -0.59% 36.29% Sep/05
Molina Healthcare 174.65 3.82 2.24% -46.71% Sep/05
RadNet 71.41 -0.89 -1.23% 14.42% Sep/05
Select Medical 13.10 0.09 0.69% -61.17% Sep/05
Tenet Healthcare 196.18 3.66 1.90% 27.89% Sep/05
Universal Health Services 190.12 4.44 2.39% -17.17% Sep/05
UnitedHealth 315.39 5.01 1.61% -47.18% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05

DaVita Healthcare Partners traded at $137.87 this Friday September 5th, increasing $2.31 or 1.70 percent since the previous trading session. Looking back, over the last four weeks, DaVita Healthcare Partners gained 7.87 percent. Over the last 12 months, its price fell by 8.13 percent. Looking ahead, we forecast DaVita Healthcare Partners to be priced at 136.73 by the end of this quarter and at 133.35 in one year, according to Trading Economics global macro models projections and analysts expectations.

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.